Filtered By:
Condition: Dementia
Education: Study
Nutrition: Vitamins
This page shows you your search results in order of date.
Order by Relevance | Date
Total 69 results found since Jan 2013.
This Overlooked Nutrient May Be The Key To Brain Power
Aging is inevitable. But have you noticed that some very elderly people still don’t miss a thing?
Some of my patients fall into this category. I’ve worked with many centenarians who remain quick-witted, with keen memories and focus.
You can be one of these people, too — an all-star senior…
Inside all of you, your cells are constantly busy dividing up to two trillion times per day. The new cells replace old, damaged, or dead cells and help you live, grow and thrive.
Human cell lines have built-in mortality. As your cells divide, there’s a limit at which their limit is reached.
There’s an internal mechanism o...
Source: Al Sears, MD Natural Remedies - August 25, 2023 Category: Complementary Medicine Authors: Jacob Tags: Brain Health Source Type: news
Too Little Sleep Destroys DNA?
I talk to my patients about the danger of not sleeping all the time. Unfortunately, it’s a common problem that affects 75 million Americans.
People who don’t sleep, or sleep poorly, have up to 400% more accidents that those who get a good night’s rest. Not getting enough sleep also increases your risk of developing chronic diseases.
Studies, including a large meta-analysis of 470,000 adults, found that those who slept less than six hours developed a:1,2,3,4,5
48% increase in the incidence of coronary heart disease
30% increased risk of dementia
15% increase in the incidence of stroke
50% cancer risk
17% higher risk ...
Source: Al Sears, MD Natural Remedies - August 25, 2023 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Health Source Type: news
5 Minutes To Better Heart Health
Americans are living through a blood pressure crisis. Maybe you, or someone you love, is one of them…
In the United States, 65% of adults over the age of 50 are living with above-normal blood pressure – increasing their risk of heart attack and stroke.
And that’s just the tip of the iceberg.
Because high blood pressure can also put you at higher risk for developing dementia later in life.1
Of course, Big Pharma doesn’t see this as a big problem. They know they can use this crisis to sell more drugs… drugs that never fail to do more harm than good.
But a new study reveals how you can lower blood pressure – a...
Source: Al Sears, MD Natural Remedies - December 23, 2022 Category: Complementary Medicine Authors: Jacob Tags: Anti-Aging Health Heart Health Source Type: news
Daily Multivitamins Linked to Improved Cognition in Older People
Taking a daily multivitamin may improve cognitive function in older people, astudy inAlzheimer ’s& Dementia has found. Taking a cocoa supplement, however, does not appear to slow cognitive decline.“There is an urgent need to identify effective strategies to preserve cognitive function to mitigate the heavy societal burden associated with Alzheimer’s disease and related dementia, which affect more than 46 million people worldwide,” wrote Laura D. Baker, Ph.D., of Wake Forest University S chool of Medicine and colleagues. Cocoa extract is rich in compounds called flavanols, and previous small studies suggest that...
Source: Psychiatr News - September 16, 2022 Category: Psychiatry Tags: Alzheimer ' s & Dementia cardiovacsular disease cocoa extract cognitive decline COSMOS-Mind multivitamin Source Type: research
Genetic Analyses Link Vitamin D Deficiency to Dementia Risk
THURSDAY, July 7, 2022 -- Low vitamin D status is associated with the risk for dementia and stroke, according to a study recently published in the American Journal of Clinical Nutrition.
Shreeya S. Navale, from the University of South Australia in...
Source: Drugs.com - Pharma News - July 7, 2022 Category: Pharmaceuticals Source Type: news
What the Science Says About the Health Benefits of Vitamins and Supplements
From multivitamins and melatonin to fiber and fish oil, Americans who are trying to boost their health and immunity have a plethora of supplements to choose from. An estimated 58% of U.S. adults ages 20 and over take dietary supplements, according to the U.S. Centers for Disease Control and Prevention, and the supplement industry is valued at more than $30 billion a year. Supplement use has been growing rapidly over the past few decades along with the wellness industry.
“The popular belief is that a supplement is going to be helpful for promoting health,” says Fang Fang Zhang, a professor at Tufts University&rs...
Source: TIME: Health - April 28, 2022 Category: Consumer Health News Authors: Sandeep Ravindran Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news
Vitamin D and brain health: an observational and Mendelian randomization study
CONCLUSIONS: Low vitamin D status was associated with neuroimaging outcomes and the risks of dementia and stroke even after extensive covariate adjustment. MR analyses support a causal effect of vitamin D deficiency on dementia but not on stroke risk.PMID:35451454 | DOI:10.1093/ajcn/nqac107
Source: The American Journal of Clinical Nutrition - April 22, 2022 Category: Nutrition Authors: Shreeya S Navale Anwar Mulugeta Ang Zhou David J Llewellyn Elina Hypp önen Source Type: research
Janssen Announces U.S. FDA Approval of INVEGA HAFYERA ™(6-month paliperidone palmitate), First and Only Twice-Yearly Treatment for Adults with Schizophrenia
TITUSVILLE, N.J., Sept. 1, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month paliperidone palmitate), the first-and-only twice-yearly injectable for the treatment of schizophrenia in adults. Before transitioning to INVEGA HAFYERA™, patients must be adequately treated with INVEGA SUSTENNA® (1-month paliperidone palmitate) for at least four months, or INVEGA TRINZA® (3-month paliperidone palmitate) for at least one 3-month injection cycle.1 The FDA approval of INVEGA ...
Source: Johnson and Johnson - September 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Selecting the right anticoagulant for stroke prevention in atrial fibrillation
CONCLUSIONS: Non-valvular AF patients on apixaban had lower rates of thromboembolic events than the patients on acenocumarol. This article will serve as a reminder of the positive health and financial outcomes of apixaban use, especially to those healthcare systems that are still oblivious to the decrease in economic burden and gain in quality-adjusted life years (QALY) by the long-term use of NOACS/ DOACS instead of the AVK anticoagulants.PMID:34286492 | DOI:10.26355/eurrev_202107_26241
Source: European Review for Medical and Pharmacological Sciences - July 21, 2021 Category: Drugs & Pharmacology Authors: N R Kundnani C I Rosca A Sharma A Tudor M S Rosca D D Nisulescu H S Branea V Mocanu D C Crisan D R Buzas S Morariu D F Lighezan Source Type: research
